ANALYSIS OF THE RANGE OF MEDICINES USED IN THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL SYSTEM

In the study, the assortment of drugs used in the treatment of diseases of the gastrointestinal system was studied according to the registration indicators using issues 23-27 of 2019 – 2023 of the "State Register of Drugs, Medical Products and Medical Equipment Allowed for Use in Medical Practice". According to the results of the analysis, in 2019, 216 assortment of trade name drugs used in diseases of the gastrointestinal system in the country were recorded by domestic manufacturers, 110 – from the countries of the Commonwealth of Independent States, and 305 – by foreign manufacturers. In 2023, there were 202, 100, 438 medicines, respectively. In 2019 – 2023, the range of drugs produced by foreign countries with international unpatented names in 38 pharmacological groups increased by 31.5 %, the range of drugs produced by local pharmaceutical enterprises increased by 11.42 %, drugs produced by the countries of the Commonwealth of Independent States decreased by 4.29 %.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-01
DOI
https://doi.org/10.5281/zenodo.13866387
Primary Topic
Healthcare Systems and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ANALYSIS OF THE RANGE OF MEDICINES USED IN THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL SYSTEM

Zenodo (CERN European Organization for Nuclear Research)
Healthcare Systems and Public Health
article

ANALYSIS OF THE RANGE OF MEDICINES USED IN THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL SYSTEM

article en

Abstract

In the study, the assortment of drugs used in the treatment of diseases of the gastrointestinal system was studied according to the registration indicators using issues 23-27 of 2019 – 2023 of the "State Register of Drugs, Medical Products and Medical Equipment Allowed for Use in Medical Practice". According to the results of the analysis, in 2019, 216 assortment of trade name drugs used in diseases of the gastrointestinal system in the country were recorded by domestic manufacturers, 110 – from the countries of the Commonwealth of Independent States, and 305 – by foreign manufacturers. In 2023, there were 202, 100, 438 medicines, respectively. In 2019 – 2023, the range of drugs produced by foreign countries with international unpatented names in 38 pharmacological groups increased by 31.5 %, the range of drugs produced by local pharmaceutical enterprises increased by 11.42 %, drugs produced by the countries of the Commonwealth of Independent States decreased by 4.29 %.

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals
Openalex Percentile: Top 56%
Healthcare Systems and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.